palmidrol and ALS - Amyotrophic Lateral Sclerosis

palmidrol has been researched along with ALS - Amyotrophic Lateral Sclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Petrosino, S; Schiano Moriello, A1
Bertollini, C; Cifelli, P; Inghilleri, M; Limatola, C; Lopergolo, D; Miledi, R; Onesti, E; Palma, E; Reyes-Ruiz, JM; Roseti, C; Ruffolo, G1
Clemente, S1

Reviews

1 review(s) available for palmidrol and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
    International journal of molecular sciences, 2020, Dec-15, Volume: 21, Issue:24

    Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocannabinoids; Ethanolamines; Humans; Inflammation; Metabolic Networks and Pathways; Multiple Sclerosis; Nervous System Diseases; Neurodegenerative Diseases; Pain; Palmitic Acids; Parkinson Disease

2020

Trials

1 trial(s) available for palmidrol and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, Mar-15, Volume: 113, Issue:11

    Topics: Action Potentials; Adult; Aged; Aged, 80 and over; Amides; Amyotrophic Lateral Sclerosis; Animals; Cell Membrane; Ethanolamines; Female; Humans; Male; Microinjections; Middle Aged; Molecular Targeted Therapy; Muscle Denervation; Muscle, Skeletal; Neuromuscular Junction; Oocytes; Palmitic Acids; Receptors, Nicotinic; Recombinant Fusion Proteins; Single-Blind Method; Xenopus laevis

2016

Other Studies

1 other study(ies) available for palmidrol and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report.
    CNS & neurological disorders drug targets, 2012, Nov-01, Volume: 11, Issue:7

    Topics: Administration, Sublingual; Amides; Amyotrophic Lateral Sclerosis; Anti-Inflammatory Agents, Non-Steroidal; Dietary Supplements; Endocannabinoids; Ethanolamines; Humans; Male; Middle Aged; Palmitic Acids; Treatment Outcome

2012